It’s a whole new era in
preeclampsia management.

Learn more about the
groundbreaking ASPRE study.

Click Here


The early weeks of pregnancy can be an exciting, but anxious time. Like many expectant mothers, you may want to know the facts about your baby’s risk for chromosomal abnormalities.
More »

Health Care Providers

For years, leading ObGyns and maternal fetal medicine specialists have recognized NTD as the innovator in prenatal screening for open neural tube defects and Down syndrome.
More »

Early Onset Preeclampsia

The sooner you know your risk for preeclampsia, the better. Patients and their physicians now have a first-of-its-kind blood test to screen for early onset preeclampsia during the first trimester.
More »

We are proud to announce that NTD Labs® is now a part of the Eurofins laboratory network. Eurofins, a worldwide leader in its field, is uniquely positioned to meet the expanding needs of NTD's customers and provides opportunity for NTD to offer new and innovative prenatal screening solutions for you and your patients. Please click here to learn more.

(References 13, 25, 36)

DISCLAIMER: Pursuant to applicable federal and/or state laboratory requirements, Eurofins NTD, LLC has established and verified the accuracy and precision of its testing services. Tests are developed and performance characteristics determined by Eurofins NTD, LLC. The methods and performance characteristics have been reviewed and approved by the New York State Department of Health.